Revolution Medicines to Report Financial Results for Second Quarter 2026 After Market Close on August 5, 2026
Go back to Revolution Medicines to Report Financial Results for Second Quarter 2026 After Market Close on August 5, 2026| (NASDAQ: RVMD) | Delayed: 210.02 -0.85 (0.4%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $210.87 | 52 Week High | $ | |||
| Open | $209.01 | 52 Week Low | $ | |||
| Day High | $211.75 | P/E | N/A | |||
| Day Low | $207.48 | EPS | $ | |||
| Volume | 885,062 | |||||

